THERAPEUTIC NUTRITION
THERAPEUTIC NUTRITION
Useful information about the needs of cats and dogs with nutritionally sensitive health conditions.
Cardiovascular Disorders
Hypertrophic Cardiomyopathy (HCM) in Cats
Hypertrophic cardiomyopathy (HCM) is the most commonly diagnosed heart disease in cats and accounts for more than 50% of feline cardiomyopathies.1,2 Certain breeds, such as Maine Coon, Ragdoll, Persians and Bengal cats are predisposed to HCM but other cats are also commonly affected.
The American College of Veterinary Internal Medicine (ACVIM) consensus guidelines identify four stages of heart disease in cats with cardiomyopathy.3
- Stage A: Cats at risk of developing cardiomyopathy
- Stage B: Subclinical cats with normal or mild left atrial enlargement (Stage B1; low risk) or cats with moderate/severe left atrial enlargement (Stage B2; high risk)
- Stage C: Cats with current or prior history of congestive heart failure (CHF) or aortic thromboembolism (ATE)
- Stage D: Cats with CHF that no longer respond to medical treatment
Cats with early HCM often escape detection because they may not have abnormal heart sounds or show clinical signs, such as respiratory distress from CHF or limb paralysis from an ATE.4
The echocardiogram is the gold standard for diagnosing HCM in cats. However cardiac biomarkers, such as N-terminal of pro-brain natriuretic peptide (NT-proBNP), can help identify high-risk HCM (B2) cats, which may be valuable before medical interventions such as general anesthesia or fluid therapy.2
For cats with heart failure or ATE, nutritional modifications can be an important part of patient care.1,3
THERAPEUTIC NUTRITION
Many cats with HCM have no heart murmur, gallop sound or arrhythmia, and cats with HCM but no murmur have increased risk of cardiac mortality.2,8
Key Messages
Presentation and outcome for hypertrophic feline cardiomyopathy are extremely variable. However, about 30% progress to heart failure.1 For cats with HCM that are in heart failure, dietary recommendations focus on:
- maintaining caloric and protein intake5,6
- Creative feeding strategies can help improve a cat’s appetite, such as offering a variety of (appropriate) food options, varied feeding locations, or warming the food to body temperature.
- Record body weight, body condition score, and muscle condition score at every veterinary visit.
- avoiding high sodium intake
- High-sodium foods and treats, often given with medication, can unintentionally add excessive sodium to a cat’s diet.3
- supplementing with taurine for cats with global left ventricular systolic dysfunction unless plasma taurine concentrations are in the normal range3,7
- supplementing with long chain omega-3 fatty acids5
- Fish oil (with DHA and EPA) may help reduce inflammatory mediators and oxidative stress, reduce platelet aggregation, and help improve appetite.
- monitoring for potassium deficiencies3
- Serum potassium concentration may be affected by medical management or underlying conditions and may need to be supplemented.
THERAPEUTIC NUTRITION
"Most cats with hypertrophic cardiomyopathy will never develop clinical signs. But if your cat does develop clinical signs, there are nutritional changes that will be an important part of your cat’s care."
Related Tools and Content:
Taking a Good Diet History
The only way to know what each patient really eats is to ask ꟷ and document the information in the medical record.
The Purina Body Condition System
The Purina Body Condition System is an easy and practical tool for assessing a pet's body composition.
How to Perform a Body Condition Assessment - Cat
Assess a cat's Body Condition Score in just 3 simple steps.
To Share With Pet Owner:
Nutrition and Heart Health
The heart is a vital organ that relies on specific nutrients and a continuous supply of energy to support and maintain a regular rate and rhythm, yet the role of nutrition in pets’ cardiac health is often overlooked.
Evaluating Your Cat’s Body Condition
Assess your cat's Body Condition in just 3 simple steps.
References
- Fox, P. R., Keene, B. W., Lamb, K., Schober, K. A., Chetboul, V., Luis Fuentes, V., Wess, G., Payne, J. R., Hogan, D. F., Motsinger-Reif, A., Häggström, J., Trehiou-Sechi, E., Fine-Ferreira, D. M., Nakamuri, R. K., Lee, P. M., Singh, M. K., Ware, W. A., Abbott, J. A., Culshaw, G., … Tachika Ohara, V. Y. (2018). International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. Journal of Veterinary Internal Medicine, 32(3), 930–943. doi: 10.1111/jvim.15122
- Luis Fuentes, V., & Wilkie, L. J. (2017). Asymptomatic hypertrophic cardiomyopathy: Diagnosis and therapy. The Veterinary Clinics of North America: Small Animal Practice, 47(5), 1041–1054. doi: 10.1016/j.cvsm.2017.05.002
- Luis Fuentes, V., Abbott, J., Chetboul, V., Côté, E., Fox, P. R., Häggström, J., Kittleson, M. D., Schober, K., & Stern, J. A. (2020). ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. Journal of Veterinary Internal Medicine, 34(3), 1062–1077. doi: 10.1111/jvim.15745
- Côté, E., Edwards, N. J., Ettinger, S. J., Fuentes, V. L., MacDonald, K. A., Scansen, B. A., Sisson, D. D., & Abbott, J. A. (2015). Management of incidentally detected heart murmurs in dogs and cats. Journal of Veterinary Cardiology, 17(4), 245–261.
- Freeman, L. M. (2010). Beneficial effects of omega-3 fatty acids in cardiovascular disease. Journal of Small Animal Practice, 51(9), 462–470.
- Freeman, L. M., & Rush, J. (2016). Nutrition in cardiovascular disorders. In F. W. K. Smith, Jr., L. P. Tilley, M. A. Oyama, & M. M. Sleeper (Eds.), Manual of canine and feline cardiology (5th ed., pp. 394–403). Elsevier.
- Pion, P. D., Kittleson, M. D., Rogers, Q. R., & Morris, J. G. (1987). Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science, 237(4816), 764–768. doi: 10.1126/science.3616607
- Payne, J. R., Borgeat, K., Connolly, D. J., Boswood, A., Dennis, S., Wagner, T., Menaut, P., Maerz, I., Evans, D., Simons, V. E., Brodbelt, D. C., & Luis Fuentes, V. (2013). Prognostic indicators in cats with hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine, 27(6), 1427–1436. doi: 10.1111/jvim.12215